blank
blank

ERDERA Clinical Trial Call – Expression of Interest template

1:1
This template lists the sections and fields applicants must complete for an Expression of Interest in the ERDERA Clinical Trial Call.

This template sets out the fields required for the Expression of Interest (EOI) in the ERDERA Clinical Trial Call. It includes sections for project data, project description, the coordinating investigator, sponsor, partners, budget, notes and declarations.

Acces this publication
blank

publication

ERDERA clinical trial call

Year of publication

2026

Author

European Rare Diseases Research Alliance (ERDERA)

You might also be interested in

2

ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases

ERDERA (the European Rare Diseases Research Alliance) has opened its Clinical Trial Call to support multinational early-phase clinical trials in rare diseases. The call will fund studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.
Erdera_IBG_2026_Poster_Social_Media

European Network Conference on Chromatinopathies (EU-CHROMNet)

November 25 - November 27
Photograph of neurons - CC BY-NC-SA 2.0 by Birth Into Being via Flickr.

NCL Foundation launches €200,000 prize to connect rare and common neurodegeneration research

The NCL Foundation has opened the Rare-to-Common Neurodegeneration Impact Prize, a €200,000 research award supporting collaborative projects that connect CLN3 Batten disease research with more common neurodegenerative or age-related disorder
EU Flags

European Commission opens call for evidence on future Joint Undertakings

Feedback is open until 14 July 2026, giving stakeholders an early opportunity to comment during the preparation of a likely legislative proposal for a Council regulation.

ERDERA's

search form